Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences Market Cap : 30.71M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 30.71M |
| November 19, 2026 | 33.55M |
| November 18, 2026 | 35.23M |
| November 17, 2026 | 36.81M |
| November 16, 2026 | 38.12M |
| November 13, 2026 | 39.10M |
| November 12, 2026 | 41.08M |
| November 11, 2026 | 42.21M |
| November 10, 2026 | 44.34M |
| November 09, 2026 | 45.35M |
| November 06, 2026 | 48.48M |
| November 05, 2026 | 44.54M |
| November 04, 2026 | 48.01M |
| November 03, 2026 | 49.63M |
| November 02, 2026 | 46.63M |
| October 30, 2026 | 44.86M |
| October 29, 2026 | 47.17M |
| October 28, 2026 | 51.87M |
| October 27, 2026 | 48.83M |
| October 26, 2026 | 52.17M |
| October 23, 2026 | 56.47M |
| October 22, 2026 | 59.36M |
| October 21, 2026 | 57.70M |
| October 20, 2026 | 55.01M |
| October 19, 2026 | 49.18M |
| Date | Value |
|---|---|
| October 16, 2026 | 49.81M |
| October 15, 2026 | 49.26M |
| October 14, 2026 | 48.77M |
| October 13, 2026 | 49.82M |
| October 12, 2026 | 52.67M |
| October 09, 2026 | 48.78M |
| October 08, 2026 | 51.01M |
| October 07, 2026 | 65.44M |
| October 06, 2026 | 120.31M |
| October 05, 2026 | 126.13M |
| October 02, 2026 | 129.31M |
| October 01, 2026 | 129.31M |
| September 30, 2026 | 134.61M |
| September 29, 2026 | 131.43M |
| September 28, 2026 | 130.37M |
| September 25, 2026 | 131.43M |
| September 24, 2026 | 132.49M |
| September 23, 2026 | 136.73M |
| September 22, 2026 | 142.03M |
| September 21, 2026 | 137.79M |
| September 18, 2026 | 137.79M |
| September 17, 2026 | 138.85M |
| September 16, 2026 | 132.49M |
| September 15, 2026 | 134.61M |
| September 14, 2026 | 136.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 54.83M |
| Vaxcyte, Inc. | 8.270B |
| Foghorn Therapeutics, Inc. | 103.14M |
| Bolt Biotherapeutics, Inc. | 10.58M |
| Connect Biopharma Holdings Ltd. | 35.90M |
Market Cap Related Metrics
| PS Ratio | 3.002 |
| Price to Book Value | 0.4008 |
| Price | 0.2843 |
| Earnings Yield | -362.2% |